Table 1.
Inoculated virus | Dose (PFU/mouse) | No. of mice with specific anti-HEV antibodies/total no. of mice (%) |
|
---|---|---|---|
22 d.p.v.a | 41 d.p.v. | ||
rVV-ORF2 | 105 | 6/6 (100) | 6/6 (100) |
106 | 9/9 (100) | 9/9 (100) | |
rVV-Δ(1-111)-ORF2 | 105 | 0/6 (0) | 4/6 (66.6) |
106 | 4/9 (44.4) | 9/9 (100) | |
WR | 106 | 0/6 (0) | 0/6 (0) |
d.p.v., days postvaccination.